-
UCB Launching Phase 1b Parkinson’s Trial Testing UCB0599 Candidate
UCB is launching a Phase 1b trial to evaluate the efficacy and safety of their therapeutic candidate UCB0599 for the treatment of Parkinson’s disease. Click here to read more about it.
Are you interested in following this trial as it progresses?
Sorry, there were no replies found.
Log in to reply.